Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.45B |
| 2 |
Visa
V
|
+$1.05B |
| 3 |
Microsoft
MSFT
|
+$1.01B |
| 4 |
Apple
AAPL
|
+$578M |
| 5 |
Norfolk Southern
NSC
|
+$545M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$1.24B |
| 2 |
McDonald's
MCD
|
+$707M |
| 3 |
JPMorgan Chase
JPM
|
+$680M |
| 4 |
Texas Instruments
TXN
|
+$678M |
| 5 |
Edwards Lifesciences
EW
|
+$664M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.8% |
| 2 | Healthcare | 2.66% |
| 3 | Financials | 2.38% |
| 4 | Consumer Discretionary | 2.05% |
| 5 | Industrials | 2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HERZ
12301
Herzfeld Credit Income Fund
HERZ
$32.2M
| $35.3K | ﹤0.01% |
+1,485
| New | +$36.3K |
|
|
FRSX
12302
Foresight Autonomous Holdings
FRSX
$3.84M
| $35.3K | ﹤0.01% |
+5,580
| New | +$45K |
|
12303
PUT
Lineage Cell Therapeutics
LCTX
$279M
| $35.3K | ﹤0.01% |
+20,900
| New | +$24.7K |
|
|
WORX
12304
DELISTED
SCWORX CORP NEW
WORX
| $35.3K | ﹤0.01% |
+8,119
| New | +$42.4K |
|
|
STAK
12305
STAK Inc
STAK
$32.7M
| $35.2K | ﹤0.01% |
+41,614
| New | +$57.3K |
|
12306
PUT
Protalix BioTherapeutics
PLX
$191M
| $35.1K | ﹤0.01% |
15,800
+5,200
| +49% | +$8.47K |
|
12307
CALL
Ironwood Pharmaceuticals
IRWD
$709M
| $35K | ﹤0.01% |
26,700
+2,300
| +9% | +$2.38K |
|
12308
Kaltura
KLTR
$211M
| $34.9K | ﹤0.01% |
+24,243
| New | +$40.9K |
|
12309
Aterian
ATER
$5.49M
| $34.8K | ﹤0.01% |
+33,165
| New | +$38.7K |
|
12310
PUT
Grove Collaborative
GROV
$46.2M
| $34.8K | ﹤0.01% |
23,200
+9,800
| +73% | +$14.3K |
|
12311
PUT
Westwater Resources
WWR
$54.5M
| $34.7K | ﹤0.01% |
+36,600
| New | +$27.5K |
|
12312
PUT
Vista Gold
VGZ
$270M
| $34.5K | ﹤0.01% |
+16,200
| New | +$21.1K |
|
12313
Ensysce Biosciences
ENSC
$5.9M
| $34.4K | ﹤0.01% |
+14,518
| New | +$31.2K |
|
|
ENFY
12314
DELISTED
Enlightify Inc
ENFY
| $34.3K | ﹤0.01% |
+42,610
| New | +$43.1K |
|
12315
New Concept Energy
GBR
$3.46M
| $34.3K | ﹤0.01% |
34,168
-10,012
| -23% | -$9.94K |
|
12316
Edesa Biotech
EDSA
$51.6M
| $34.2K | ﹤0.01% |
14,032
-9,482
| -40% | -$21.9K |
|
12317
PUT
Erasca
ERAS
$6.38B
| $34.2K | ﹤0.01% |
+15,700
| New | +$25K |
|
12318
CALL
Ispire Technology
ISPR
$90.7M
| $34K | ﹤0.01% |
13,300
-18,000
| -58% | -$52.3K |
|
12319
CALL
Purple Innovation
PRPL
$42.4M
| $34K | ﹤0.01% |
1,456
-2,676
| -65% | -$62.6K |
|
12320
CALL
Milestone Pharmaceuticals
MIST
$146M
| $34K | ﹤0.01% |
17,000
-11,900
| -41% | -$20.9K |
|
12321
CALL
TTEC Holdings
TTEC
$132M
| $33.9K | ﹤0.01% |
+10,100
| New | +$41.4K |
|
12322
Brenmiller Energy
BNRG
$1.1M
| $33.8K | ﹤0.01% |
+612
| New | +$44.4K |
|
12323
PUT
Comtech Telecommunications
CMTL
$50.6M
| $33.8K | ﹤0.01% |
13,100
-12,500
| -49% | -$28.6K |
|
12324
Network-1 Technologies
NTIP
$36.6M
| $33.7K | ﹤0.01% |
+22,451
| New | +$32.6K |
|
|
ORKT
12325
Orangekloud Technology Inc
ORKT
$5.84M
| $33.5K | ﹤0.01% |
+16,601
| New | +$45.6K |
|
Similar funds
Citadel Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, Citadel Advisors held 14,587 positions worth $657B, up 14% from $576B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citadel Advisors's Q3 2025 filing shows 2,292 new, 5,365 increased, 4,887 reduced and 1,963 closed positions. Its largest new stake was Permian Resources: 18,381,735 shares worth $235M. The largest sale was Hess, an estimated $1.24B.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3.3% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q3 2025 buy was Permian Resources: 18,381,735 shares worth $235M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q3 2025, an estimated $1.45B increase.
- Citadel Advisors's biggest Q3 2025 reduction was McDonald's, cutting an estimated $707M.
- Citadel Advisors fully exited Hess in Q3 2025, selling an estimated $1.24B.
- Citadel Advisors's ten largest holdings make up 25% of its $657B portfolio in Q3 2025.
- Citadel Advisors opened 2,292 new positions and closed 1,963 in Q3 2025.
- Citadel Advisors's portfolio value rose 14% quarter-over-quarter to $657B.
Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.